Skip navigation | ||
|
||
Medical Encyclopedia |
|
Other encyclopedia topics: | A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 |
Contents of this page: | |
|
|
|
Alternative Names Return to top
Plasma cell dyscrasia; Plasma cell myeloma; Malignant plasmacytoma; Plasmacytoma of bone; Myeloma - multipleDefinition Return to top
Multiple myeloma is a cancer of the plasma cells in bone marrow.
Causes Return to top
Plasma cells help the body's immune system fight disease by producing substances called antibodies. Multiple myeloma occurs when plasma cells grow out of control. Too many plasma cells can form a tumor in the bone marrow called a myeloma. Many tumors are called multiple myeloma.
The excess growth of plasma cells interferes with body's ability to make red blood cells, white blood cells, and platelets. This causes anemia and makes a person more likely to get infections and have abnormal bleeding.
As the cancer cells grow in the bone marrow, they cause pain and destruction of the bones. If the bones in the spine are affected, it can put pressure on the nerves, resulting in numbness or paralysis.
Multiple myeloma mainly affects older adults. A history of radiation therapy raises your risk for this type of cancer.
Symptoms Return to top
Exams and Tests Return to top
Blood tests can help diagnose this disease. Such tests may include:
Bone x-rays show fractures or hollowed out areas of bone. If your doctor suspects this type of cancer, a bone marrow biopsy will be performed.
This disease may also alter the results of the following tests:
Treatment Return to top
The goal of treatment is to relieve symptoms.
People who have mild disease or have a doubtful diagnosis are usually carefully monitored without treatment. Some people have a slow-developing form of multiple myeloma that takes years to cause symptoms.
Treatment begins when the disease becomes worse or causes symptoms.
Chemotherapy and radiation therapy may be performed to relieve bone pain or treat a bone tumor
Bone marrow transplantation in younger patients has been shown to increase disease-free and overall survival, but it has significant risks.
Medications for multiple myeloma include thalidomide, lenalidomide (Revlimid), and bortezomib (Velcade).
Patients with multiple myeloma should drink plenty of fluids to prevent dehydration and help maintain proper kidney function.
Chemotherapy and transplants rarely lead to a permanent cure.
Support Groups Return to top
The stress of illness may be eased by joining a support group whose members share common experiences and problems. See: Cancer - support group
Outlook (Prognosis) Return to top
Survival of people with multiple myeloma depends on the patient's age and the stage of disease. Some cases are very aggressive, while others take years to get worse.
Possible Complications Return to top
Kidney failure is a frequent complication. Other complications may include:
When to Contact a Medical Professional Return to top
Call your health care provider if you experience decreased urine output.
Call your provider if you have multiple myeloma and infection develops, or numbness, loss of movement, or loss of sensation develops.
References Return to top
Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:pp. 1429-33. Update Date: 7/11/2008 Updated by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Home | Health Topics | Drugs & Supplements | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Disclaimers | Copyright | Privacy | Accessibility | Quality Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 25 September 2008 |